
Which PEPFAR Investments Drive HIV Outcomes? Informing PEPFAR Transition and Scale-Down
Overview As PEPFAR faces increased pressure to transition and scale down, understanding which of its investments most effectively drive HIV outcomes can help inform future directions. This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023, looking at spending in three areas: (1) core-services; (2) targeted/stand-alone programs; and (3) non-service…